Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2760 results

Press release / Feb 18, 2026

Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib, a highly selective oral BTK inhibitor, was well-…
Clinical Trials / Mar 20, 2026

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Clinical Trials / Mar 19, 2026

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Clinical Trials / Mar 20, 2026

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Clinical Trials / Mar 12, 2026

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical Trials / Mar 05, 2026

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Clinical Trials / Mar 05, 2026

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
Clinical Trials / Mar 09, 2026

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Clinical Trials / Feb 13, 2026

Remibrutinib in Real-world Clinical Practice - a US Sub-study
Clinical Trials / Mar 05, 2026

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients